iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 1450

Identifiers

  • Canonical SMILES:
    FC(F)Oc1cccc(N[C@@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc23)c1
  • IUPAC name:
    6-chloro-3-[(3-chlorophenyl)methyl]-3-[3-(difluoromethoxy)anilino]-1H-indol-2-one
  • InChi:
    InChI=1S/C22H16Cl2F2N2O2/c23-14-4-1-3-13(9-14)12-22(18-8-7-15(24)10-19(18)27-20(22)29)28-16-5-2-6-17(11-16)30-21(25)26/h1-11,21,28H,12H2,(H,27,29)/t22-/m1/s1
  • InChiKey:
    MHLHMGUEMDCLJB-JOCHJYFZSA-N

External links


168318091

External search

Bibliography (1)

Publication Name
Li Chen, Jing Zhang, Zhuming Zhang, Song Yang, F. Hoffmann-La Roche Ag. . Oxindole derivatives as anticancer agents None. 19

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MDM2-Like / P53 8.59 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 448.06 g/mol
HBA 4
HBD 2
HBA + HBD 6
AlogP 6.39
TPSA 50.36
RB 6
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2008034736 19 MDM2
Q00987

Biochemical assay Time-Resolved FRET pIC50 (half maximal inhibitory concentration, -log10) 8.59
Ta Structure Name Drugbank ID
0.5904 OPC-14523 DB05422
0.5588 Aripiprazole DB01238
0.5503 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone DB02058
0.5144 OPC-51803 DB05838
0.5138 N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide DB07608
0.5000 Vesnarinone DB12082
0.5000 Bentiromide DB00522
0.4975 SAR-405838 DB12541
0.4817 Encainide DB01228
0.4815 Linopirdine DB13806
0.4710 Pyroquilon DB02756
0.4709 Carteolol DB00521
0.4709 Aripiprazole lauroxil DB14185
0.4702 Elacestrant DB06374
0.4522 Oxyphenisatin acetate DB14627